SUVENPHAR.NS
Suven Pharmaceuticals Limited [SUVENPHAR.NS] Stock Forecast
Buy or Sell ? Support and Resistance
What is MACD and how to read it?
How RSI can help?
RSI : 000
SUVENPHAR.NS Stock Summary
Top 10 Correlated Stocks
SUVENPHAR.NS
In the News
SUVENPHAR.NS Financial details
Company Rating
-
Market Cap
159.26B
Income
3.71B
Revenue
11.68B
Book val./share
-
Cash/share
-
Dividend
-
Dividend %
-
Employees
1.19K
Optionable
No
Shortable
Yes
Earnings
23 May 2024
P/E
43.24
Forward P/E
-
PEG
-23.72
P/S
14.36
P/B
9.65
P/C
-
P/FCF
-
Quick Ratio
7.57
Current Ratio
10.4
Debt / Equity
-
LT Debt / Equity
-
-
-
EPS (TTM)
14.58
EPS next Y
-
EPS next Q
-
EPS this Y
-9.37%
EPS next Y
-
EPS next 5Y
-
EPS last 5Y
30.38%
Revenue last 5Y
29.62%
Revenue Q/Q
-4.86%
EPS Q/Q
-41.21%
-
-
-
-
SMA20
1.67%
SMA50
5.24%
SMA100
-8.95%
Inst Own
-
Inst Trans
-
ROA
20%
ROE
47%
ROC
0.29%
Gross Margin
59%
Oper. Margin
44%
Profit Margin
33%
Payout
-
Shs Outstand
-
Shs Float
-
-
-
-
-
Target Price
-
52W Range
463.4-768.0
52W High
+48.06%
52W Low
+145.59%
RSI
47.87
Rel Volume
0.23
Avg Volume
523.92K
Volume
121.69K
Perf Week
-5.42%
Perf Month
-1.8%
Perf Quarter
-14.32%
Perf Half Y
-10.25%
-
-
-
-
Beta
1.366
-
-
Volatility
36.62%, 46.31%
Prev Close
0.06%
Price
1137.1
Change
-1.97%
Company Profile
- Volume Average 523.92K
- Market Capitalization 159.26B
- Employee 1.19K
- CEO Dr. Sudhir Kumar Singh Ph.D.
- Headquarters Hyderabad,IN
- IPO Date 2020-03-09
-
Website
https://www.suvenpharm.com 
Suven Pharmaceuticals Limited operates as a bio-pharmaceutical company in India, the United States, Europe, and internationally. It develops, manufactures, and sells new chemical entity-based intermediates, active pharmaceutical ingredients, specialty chemicals, and formulated drugs under contract research and manufacturing services for pharmaceutical, biotechnology, and chemical companies. The company was incorporated in 2018 and is headquartered in Hyderabad, India. Suven Pharmaceuticals Limited is a subsidiary of Jasti Property and Equity Holdings Private Limited.
